Latest Close
$0.16
News
ADIA
Adial Pharmaceuticals, Inc News
This news view pulls recent coverage and headlines tied to ADIA.
1y Change
$0.08 (+100.00%)
Market Cap
$15,104,751.00
Sector
Financial Services
Industry
Shell Companies
Recommendation
none
Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov
TMX Newsfile • May 20, 2026
Read articleADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026
TMX Newsfile • May 15, 2026
Read articleADIA Nutrition Announces IRB Approval of All Four Clinical Studies and Registration of Kidney Health Study on ClinicalTrials.gov
TMX Newsfile • May 11, 2026
Read articleAdia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)
TMX Newsfile • May 5, 2026
Read articleAdia Nutrition Announces Three Pivotal Clinical Studies Receive Major IRB Milestone - Final Approval Now Clearly in Sight
TMX Newsfile • Apr 28, 2026
Read articleAdia Nutrition, Inc. Looking to Acquire Larger Property to Expand Flagship Clinic in Winter Park, Reports Strong Operational Momentum in Q1 2026 and Provides Optimistic Outlook for Remainder of the Year
TMX Newsfile • Apr 22, 2026
Read article